How should I manage a patient with suspected recurrent herpes zoster on the buttocks who had a prior episode 30 years ago?

Management of Suspected Recurrent Herpes Zoster on the Buttocks

This is almost certainly NOT recurrent herpes zoster—true recurrence in the same dermatome after 30 years is extraordinarily rare in immunocompetent patients, and you should strongly consider alternative diagnoses, particularly recurrent genital herpes simplex virus (HSV) infection, which commonly affects the buttocks and sacral area. 1

Critical Diagnostic Distinction

The key issue here is distinguishing between herpes zoster (shingles) and genital HSV infection:

• Herpes zoster recurrence in the same dermatome is exceptionally uncommon in immunocompetent individuals, though it can occur in different dermatomes after many years 1
• Genital HSV (particularly HSV-2) commonly affects the buttocks and sacral region and is characterized by recurrent episodes in the same location 2
• The 30-year interval and same anatomic location strongly suggest this is recurrent genital HSV rather than herpes zoster 2, 3

Immediate Clinical Assessment

Examine the rash carefully for distinguishing features:

• Herpes zoster typically presents as a unilateral, dermatomal vesicular rash that does not cross the midline 4
• Genital HSV presents as grouped vesicles on an erythematous base, often bilateral or localized to buttocks/perianal area, and frequently recurs in the exact same spot 2
• Check for prodromal symptoms: HSV often has localized tingling or burning before eruption; zoster may have more severe pain 4

Rule Out Immunocompromise

Before accepting a diagnosis of recurrent zoster, assess immune status:

• Obtain HIV testing, as recurrent or atypical zoster presentations suggest immunosuppression 4, 5
• Review medications for immunosuppressive agents 5
• Consider checking complete blood count and basic metabolic panel 4

Treatment Approach

If Clinical Features Suggest Genital HSV (Most Likely):

Treat as recurrent genital herpes with episodic therapy:

• Acyclovir 400 mg orally three times daily for 5 days, OR 2
• Acyclovir 800 mg orally twice daily for 5 days, OR 2
• Valacyclovir 1 g orally twice daily for 7-10 days 2

Treatment should be initiated during prodrome or within 1 day of lesion onset for maximum benefit 2

If Clinical Features Suggest Herpes Zoster:

Initiate antiviral therapy within 72 hours of rash onset:

• Acyclovir 800 mg orally five times daily for 7-10 days (standard regimen) 4
• Valacyclovir 1 g orally twice daily for 7-10 days (more convenient dosing) 4
• Famciclovir 250 mg orally three times daily for 7-10 days 2

All patients ≥50 years with suspected zoster require urgent antiviral therapy to reduce risk of post-herpetic neuralgia 4, 6

Diagnostic Confirmation

Obtain laboratory confirmation to guide future management:

• PCR testing of vesicular fluid is the gold standard for distinguishing VZV from HSV and determining HSV type 6
• Viral culture can identify the pathogen but is less sensitive than PCR 6
• Type-specific HSV serology (HSV-1 vs HSV-2 IgG) may help establish prior infection patterns 2

Common Pitfalls to Avoid

• Do not assume "shingles" based solely on patient history from 30 years ago—memory of prior diagnoses is often inaccurate 1
• Do not use topical acyclovir—it is substantially less effective than oral therapy for both HSV and VZV 3, 4
• Do not delay treatment while awaiting laboratory confirmation if clinical suspicion is high 4
• Do not prescribe abbreviated 1-3 day courses—full duration therapy is required 4

Counseling and Follow-Up

If genital HSV is confirmed:

• Counsel about recurrent nature of HSV, asymptomatic viral shedding, and sexual transmission 2
• Discuss suppressive therapy (acyclovir 400 mg orally twice daily) if patient has ≥6 recurrences per year 2, 3
• Advise abstinence during lesions and encourage condom use with partners 2

If herpes zoster is confirmed:

• Discuss zoster vaccination after acute episode resolves (wait at least 2 months) 4
• Recombinant zoster vaccine (Shingrix) is preferred and recommended even after an episode 4
• Monitor for post-herpetic neuralgia development 4, 6

Infection Control

Until diagnosis is clarified, implement appropriate precautions:

• Cover lesions completely to prevent transmission 4
• Avoid contact with pregnant women, newborns, and immunocompromised individuals until all lesions are crusted 4
• Patient may return to work once lesions are fully covered or crusted 4